1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > InSightec Ltd. - Product Pipeline Analysis, 2016 Update

InSightec Ltd. - Product Pipeline Analysis, 2016 Update

  • September 2016
  • -
  • Global Data
  • -
  • 39 pages

Summary

Insightec Ltd. (InSightec), a subsidiary of Elbit Imaging Ltd. is a medical device company that develops and markets MR guided Focused Ultrasound (MRgFU) technology based medical devices. The company provides products through divisions such as neurosurgery, oncology and womens’ health. It offers services such as commercial development advisory, free professional services, free platform upgrade, onsite support, parts warranty, periodic maintenance, remote technical support, and software upgrades. InSightec’s products are used in the treatment of tumor. The company operates in China, Israel, Japan and the UK. InSightec is headquartered in Tirat Carmel, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InSightec Ltd.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

InSightec Ltd. - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2


InSightec Ltd. Company Overview 7
InSightec Ltd. Company Snapshot 7
InSightec Ltd. Pipeline Products and Clinical Trials Overview 8
InSightec Ltd. - Pipeline Analysis Overview 10
Key Facts 10
InSightec Ltd. - Major Products and Services 11
InSightec Ltd. Pipeline Products by Development Stage 12
InSightec Ltd. Clinical Trials by Trial Status 13
InSightec Ltd. Pipeline Products Overview 16
ExAblate - Brain Cancer 16
ExAblate - Brain Cancer Product Overview 16
ExAblate - Brain Cancer Clinical Trial 17
ExAblate - Breast Cancer 19
ExAblate - Breast Cancer Product Overview 19
ExAblate - Breast Cancer Clinical Trial 20
ExAblate - Liver Cancer 21
ExAblate - Liver Cancer Product Overview 21
ExAblate - Prostate Cancer 22
ExAblate - Prostate Cancer Product Overview 22
ExAblate - Prostate Cancer Clinical Trial 23
ExAblate Neuro 24
ExAblate Neuro Product Overview 24
ExAblate Neuro Clinical Trial 25
InSightec Ltd. - Key Competitors 29
InSightec Ltd. - Key Employees 30
InSightec Ltd. - Locations And Subsidiaries 31
Head Office 31
Other Locations and Subsidiaries 31
Recent Developments 32
InSightec Ltd., Recent Developments 32
Aug 25, 2016: Pivotal Study Results Published In New England Journal Of Medicine Confirm Safety And Efficacy Of Insightec's Exablate Neuro System For The Treatment Of Essential Tremor 32
Aug 01, 2016: Insightec Signs Distribution Agreements In Korea, Slovakia and Lithuania 32
Jul 27, 2016: Coverage of INSIGHTEC's Exablate for Pain Palliation of Bone Metastases Expands to 99.8 Million Members in the US 33
Jul 11, 2016: FDA approves first MRI-guided focused ultrasound device to treat essential tremor 33
May 24, 2016: Health Canada Approves Insightec's Exablate Neuro System For The Treatment Of Essential Tremor 34
Mar 23, 2016: INSIGHTEC Broadcasts The First, Live Exablate Neuro Brain Treatment At ISTU 2016 35
Jan 08, 2016: INSIGHTEC Announces Changes in Leadership and Appoints a New General Manager 36
Dec 31, 2015: INSIGHTEC Appoints Maurice R. Ferre, MD, as CEO 36
Dec 22, 2015: Insightec Announces Continued Success In Securing Positive Coverage Policies With BCBS 36
Nov 30, 2015: Elbit Imaging Announces That InSightec's Exablate Neuro System Has Been Approved by the Korean Ministry of Food and Drug Safety 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
InSightec Ltd. Pipeline Products and Clinical Trials Overview 8
InSightec Ltd. Pipeline Products by Equipment Type 8
InSightec Ltd. Pipeline Products by Indication 9
InSightec Ltd. Clinical Trials by Trial Status 9
InSightec Ltd., Key Facts 10
InSightec Ltd., Major Products and Services 11
InSightec Ltd. Number of Pipeline Products by Development Stage 12
InSightec Ltd. Pipeline Products Summary by Development Stage 12
InSightec Ltd. Clinical Trials by Trial Status 13
InSightec Ltd. Clinical Trials Summary 14
ExAblate - Brain Cancer - Product Status 16
ExAblate - Brain Cancer - Product Description 16
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Blood-brain Barrier Disruption Using Transcranial MRI-guided Focused Ultrasound with Intravenous Ultrasound Contrast Agents in the Treatment of Brain Tumours with Doxorubicin 17
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Transcranial MRI-guided Focused Ultrasound Surgery in the Treatment of Brain Tumors 17
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Transcranial MRI-guided Focused Ultrasound Surgery in the Treatment of Brain Tumors 18
ExAblate - Breast Cancer - Product Status 19
ExAblate - Breast Cancer - Product Description 19
ExAblate - Breast Cancer - A Clinical Study to Evaluate the Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast Carcinomas 20
ExAblate - Liver Cancer - Product Status 21
ExAblate - Liver Cancer - Product Description 21
ExAblate - Prostate Cancer - Product Status 22
ExAblate - Prostate Cancer - Product Description 22
ExAblate - Prostate Cancer - Focal MR-guided Focused Ultrasound Treatment of Localized Low and Intermediate Risk Prostate Cancer: Feasibility Study 23
ExAblate - Prostate Cancer - Focal MR-guided Focused Ultrasound Treatment of Localized Low-intermediate Risk Prostate Cancer: Feasibility Study 23
ExAblate Neuro - Product Status 24
ExAblate Neuro - Product Description 24
ExAblate Neuro - A Continued Access Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects 25
ExAblate Neuro - A Feasibility Clinical Trial of the Magnetic Resonance Guided Focused Ultrasound (MRgFUS) for the Management of Treatment-refractory Movement Disorders 25
ExAblate Neuro - A Feasibility Clinical Trial of the Management of the Medically-refractory Dyskinesia Symptoms of Advanced Idiopathic Parkinson's Disease with Unilateral Lesioning of the Globus Pallidum Using the ExAblate Transcranial System 26
ExAblate Neuro - A Feasibility Clinical Trial of the Management of the Medically-refractory Motor Symptoms of Advanced Idiopathic Parkinson's Disease with Staged, Unilateral Lesioning of the Subthalamic Nucleus using the ExAblate Transcranial System 26
ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Bilateral Anterior Capsulotomy in the Treatment of Medication-refractory MDD 27
ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the Treatment of Medication-refractory Tremor Dominant Idiopathic Parkinson's Disease 27
ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound Treatment of Medication-refractory OCD 27
ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of MR-Guided Focused Ultrasound Ablation Therapy in the Treatment of Subcortical Lesional Epilepsy 28
ExAblate Neuro - A Pivotal Study to Evaluate the Effectiveness and Safety of Exablate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects 28
InSightec Ltd., Key Employees 30
InSightec Ltd., Other Locations 31

List of Figures
InSightec Ltd. Pipeline Products by Equipment Type 9
InSightec Ltd. Pipeline Products by Development Stage 12
InSightec Ltd. Clinical Trials by Trial Status 13

Companies Mentioned
WideMed Technologies LTD.
Trig Medical Ltd.
Alma Lasers, Ltd.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
AngioDynamics, Inc. (ANGO) - Product Pipeline Analysis, 2016 Update

AngioDynamics, Inc. (ANGO) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • September 2016
  • by Global Data

Summary AngioDynamics, Inc. (AngioDynamics) is a provider of medical, surgical and diagnostic devices. Its major products include peripheral vascular products, radiofrequency ablation and NanoKnife systems, ...

Philips Healthcare - Product Pipeline Analysis, 2016 Update

Philips Healthcare - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • March 2016
  • by Global Data

Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring ...

Loxo Oncology, Inc. (USA)

Loxo Oncology, Inc. (USA)

  • $ 2300
  • Company report
  • March 2016
  • by Global Industry Analysts

This report presents quick facts about Loxo Oncology, Inc., which is principally involved in Pharmaceuticals Business. Illustrated with 46 tables, the report showcases the company's recent news stories ...

Biocept, Inc. (usa)

February 2016 $ 2750

Download Unlimited Documents from Trusted Public Sources

Irccs - Company Report, 2017

  • January 2017
    81 pages
  • Cancer  

    Oncology  

    Hospital  

  • Europe  

    Italy  

View report >

Healthcare Industry - Analyst Report, November 2016

  • November 2016
    12 pages
  • Pancreatic Canc...  

  • Europe  

    United States  

View report >

VolitionRx Limited - Analyst Report, September 2016

  • September 2016
    12 pages
  • Colorectal Canc...  

  • Europe  

    United States  

View report >

Related Market Segments :

Ultrasound

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.